← Back to Search

Alpha-1 Adrenergic Receptor Antagonist

Tamsulosin for Urinary Retention

Phase 2
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women 18-80 undergoing outpatient minimally invasive hysterectomy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will test whether tamsulosin can help women who need a hysterectomy to pee and be discharged sooner.

Eligible Conditions
  • Urinary Retention

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to Spontaneous Void
Secondary outcome measures
Time to Discharge From the Post-anesthesia Care Unit

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Tamsulosin- intervention groupExperimental Treatment1 Intervention
Group II: Placebo groupPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tamsulosin
2002
Completed Phase 4
~16790

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
511 Previous Clinical Trials
148,127 Total Patients Enrolled
1 Trials studying Urinary Retention
120 Patients Enrolled for Urinary Retention

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any eligibility requirements to join this trial?

"200 participants experiencing urinary retention aged between 18 and 80 have the opportunity to join this trial. Of particular note, female candidates aged 18-80 undergoing outpatient minimally invasive hysterectomy are eligible for enrolment."

Answered by AI

What maladies can Tamsulosin be prescribed to address?

"Through the use of Tamsulosin, physicians are able to effectively treat bladder outlet obstruction, ureteral calculus, and benign prostatic hyperplasia (BPH)."

Answered by AI

What other investigations involving Tamsulosin have been conducted thus far?

"Currently, 13 studies are underway to research Tamsulosin. Of these active trials, 3 have progressed into Phase 3. Most of the investigations for this drug take place in Baden-Aargau; however there are also clinical sites located elsewhere that carry out its testing."

Answered by AI

Is this experiment seeking to enroll participants of a certain age threshold?

"This trial is enrolling individuals who are above the legal age of consent and below 80 years old."

Answered by AI

Does this clinical research have any ongoing openings for participants?

"Affirmative. The information located on clinicaltrials.gov reveals that this medical trial is actively enrolling participants. Starting from April 16th 2021, the study has been recruiting for 200 patients distributed across 2 sites."

Answered by AI

To what extent is this medical experiment being conducted with participants?

"Affirmative. According to the information hosted on clinicaltrials.gov, recruitment for this medical trial is still ongoing since it was first put up on April 16th 2021 and updated most recently May 17th 2022. The study needs 200 individuals from 2 different locations to take part in the research."

Answered by AI

Has the FDA sanctioned Tamsulosin for therapeutic use?

"Since this is a Phase 2 trial, which indicates that Tamsulosin has been tested for safety but not efficacy, our team at Power estimated its safety as a score of two."

Answered by AI
~41 spots leftby Mar 2025